Thrombin

From Proteopedia

Jump to: navigation, search

Human thrombin large (red) and small (green) subunits complex with prolinamide derivative (PDB code 1ppb)

3D Structures of thrombin

Updated on 28-December-2017

References

  1. Fenton JW 2nd. Thrombin specificity. Ann N Y Acad Sci. 1981;370:468-95. PMID:7023326
  2. 2.0 2.1 Coughlin SR. Thrombin signalling and protease-activated receptors. Nature. 2000 Sep 14;407(6801):258-64. PMID:11001069 doi:http://dx.doi.org/10.1038/35025229
  3. Crawley JT, Lam JK, Rance JB, Mollica LR, O'Donnell JS, Lane DA. Proteolytic inactivation of ADAMTS13 by thrombin and plasmin. Blood. 2005 Feb 1;105(3):1085-93. Epub 2004 Sep 23. PMID:15388580 doi:http://dx.doi.org/10.1182/blood-2004-03-1101
  4. 4.0 4.1 4.2 4.3 4.4 4.5 4.6 Lane DA, Philippou H, Huntington JA. Directing thrombin. Blood. 2005 Oct 15;106(8):2605-12. Epub 2005 Jun 30. PMID:15994286 doi:http://dx.doi.org/10.1182/blood-2005-04-1710
  5. Takagi T, Doolittle RF. Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin. Biochemistry. 1974 Feb 12;13(4):750-6. PMID:4811064
  6. Miljic P, Heylen E, Willemse J, Djordjevic V, Radojkovic D, Colovic M, Elezovic I, Hendriks D. Thrombin activatable fibrinolysis inhibitor (TAFI): a molecular link between coagulation and fibrinolysis. Srp Arh Celok Lek. 2010 Jan;138 Suppl 1:74-8. PMID:20229688
  7. 7.0 7.1 7.2 7.3 Huntington JA. Natural inhibitors of thrombin. Thromb Haemost. 2014 Apr 1;111(4):583-9. doi: 10.1160/TH13-10-0811. Epub 2014 Jan, 30. PMID:24477356 doi:http://dx.doi.org/10.1160/TH13-10-0811
  8. 8.0 8.1 8.2 8.3 8.4 Huntington JA. Thrombin inhibition by the serpins. J Thromb Haemost. 2013 Jun;11 Suppl 1:254-64. doi: 10.1111/jth.12252. PMID:23809129 doi:http://dx.doi.org/10.1111/jth.12252
  9. Esmon CT. The regulation of natural anticoagulant pathways. Science. 1987 Mar 13;235(4794):1348-52. PMID:3029867
  10. Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem. 1994 Dec 16;269(50):31869-80. PMID:7989361
  11. 11.0 11.1 Lu D, Kalafatis M, Mann KG, Long GL. Comparison of activated protein C/protein S-mediated inactivation of human factor VIII and factor V. Blood. 1996 Jun 1;87(11):4708-17. PMID:8639840
  12. Duga S, Asselta R, Tenchini ML. Coagulation factor V. Int J Biochem Cell Biol. 2004 Aug;36(8):1393-9. PMID:15147718 doi:http://dx.doi.org/10.1016/j.biocel.2003.08.002
  13. Saenko EL, Shima M, Sarafanov AG. Role of activation of the coagulation factor VIII in interaction with vWf, phospholipid, and functioning within the factor Xase complex. Trends Cardiovasc Med. 1999 Oct;9(7):185-92. PMID:10881749
  14. Camire, R. M. (2010). Platelet factor V to the rescue. Blood, 115(4), 753-754. DOI: 10.1182/blood-2009-11-252619
  15. Berkner KL. Vitamin K-dependent carboxylation. Vitam Horm. 2008;78:131-56. doi: 10.1016/S0083-6729(07)00007-6. PMID:18374193 doi:http://dx.doi.org/10.1016/S0083-6729(07)00007-6
  16. 16.0 16.1 16.2 16.3 16.4 16.5 16.6 16.7 Lechtenberg BC, Freund SM, Huntington JA. An ensemble view of thrombin allostery. Biol Chem. 2012 Sep;393(9):889-98. doi: 10.1515/hsz-2012-0178. PMID:22944689 doi:http://dx.doi.org/10.1515/hsz-2012-0178
  17. Tijburg PN, van Heerde WL, Leenhouts HM, Hessing M, Bouma BN, de Groot PG. Formation of meizothrombin as intermediate in factor Xa-catalyzed prothrombin activation on endothelial cells. The influence of thrombin on the reaction mechanism. J Biol Chem. 1991 Feb 25;266(6):4017-22. PMID:1995649
  18. Bobofchak KM, Pineda AO, Mathews FS, Di Cera E. Energetic and structural consequences of perturbing Gly-193 in the oxyanion hole of serine proteases. J Biol Chem. 2005 Jul 8;280(27):25644-50. Epub 2005 May 12. PMID:15890651 doi:http://dx.doi.org/10.1074/jbc.M503499200
  19. 19.0 19.1 19.2 19.3 Bode W, Mayr I, Baumann U, Huber R, Stone SR, Hofsteenge J. The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J. 1989 Nov;8(11):3467-75. PMID:2583108
  20. Page MJ, Di Cera E. Evolution of peptidase diversity. J Biol Chem. 2008 Oct 31;283(44):30010-4. doi: 10.1074/jbc.M804650200. Epub 2008 , Sep 3. PMID:18768474 doi:http://dx.doi.org/10.1074/jbc.M804650200
  21. Schechter I, Berger A. On the size of the active site in proteases. I. Papain. 1967. Biochem Biophys Res Commun. 2012 Aug 31;425(3):497-502. doi:, 10.1016/j.bbrc.2012.08.015. PMID:22925665 doi:http://dx.doi.org/10.1016/j.bbrc.2012.08.015
  22. Huntington JA. Molecular recognition mechanisms of thrombin. J Thromb Haemost. 2005 Aug;3(8):1861-72. PMID:16102053 doi:http://dx.doi.org/10.1111/j.1538-7836.2005.01363.x
  23. Zhang E, Tulinsky A. The molecular environment of the Na+ binding site of thrombin. Biophys Chem. 1997 Jan 31;63(2-3):185-200. PMID:9108691
  24. Li W, Johnson DJ, Esmon CT, Huntington JA. Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin. Nat Struct Mol Biol. 2004 Sep;11(9):857-62. Epub 2004 Aug 15. PMID:15311269 doi:10.1038/nsmb811
  25. Spronk HM, Borissoff JI, ten Cate H. New insights into modulation of thrombin formation. Curr Atheroscler Rep. 2013 Nov;15(11):363. doi: 10.1007/s11883-013-0363-3. PMID:24026641 doi:http://dx.doi.org/10.1007/s11883-013-0363-3

With participation by User:Cody Couperus

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky, Cody Couperus, Joel L. Sussman

Personal tools